Pfizer closes lab in UK – claims outsourcing innovation

Stian Westlake, director of research at the National Endowment for Science, Technology and the Arts, agrees that the trend towards open innovation means that instead of wooing a few high-profile investors, ministers must now wade through rules and regulations to ensure the UK nurtures the kinds of innovative start-ups where the most exciting R&D now takes place.

via The Observer.

How much of this is, as they claim, to do with

focusing our efforts…where we…can deliver the greatest medical and commercial impact

or with not believing in their ability to innovate in the UK rather than any burgeoning investment in University or “open” research?


What do you think about what I wrote?

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s